Compare Charles River Laboratories Intl. Inc (CRL) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares Bitcoin Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $281.43 (market cap $13.46B), while iShares Bitcoin Trust trades at $35.9. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| CRL | IBIT | |
|---|---|---|
Market Cap | $13.46B | — |
Sector | Health | Crypto-linked |
52-Week High | $282.00 | $71.29 |
52-Week Low | $145.57 | $33.29 |
Enterprise Value | $16.30B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $286.36, up 3.38% today and near its 52-week high of $277.07. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent Q2 2026 results exceeded expectations with EPS of $3.02 versus $2.77 estimate, driving positive sentiment. However, valuation metrics remain elevated with P/E at 684.85 and negative profitability margins.
While technical indicators and analyst consensus (72% buy ratings) support near-term upside, fundamental concerns persist with negative net income margin (-5.96%) and ROE (-7.7%). The stock faces execution risks in maintaining earnings momentum amid competitive pressures. Current price exceeds consensus target of $277.29, suggesting limited near-term upside potential despite positive business inflection.
IBIT trades at $35.9, down 0.91% on the day, reflecting a bearish technical outlook with moving averages signaling strong selling pressure. The stock faces resistance at $36 and $37, with support at $35. Recent news highlights institutional interest, with Alpha Zero LLC increasing its stake by 43.8% in Q1 2026 (SEC filing, 2026-07-21).
The outlook remains cautious due to the bearish technical structure and lack of fundamental financial data. Key risks include market volatility and competitive pressures. Analyst sentiment is mixed, with some advocating long-term value while technical indicators suggest near-term weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
